JPRN-UMIN000039125招募中未知
Effect of pemafibrate on lipid and bile acid metabolism in patients with fatty liver or primary biliary cholangitis - Effect of pemafibrate on lipid and bile acid metabolism in patients with fatty liver or primary biliary cholangitis
适应症
试验速览
- 阶段
- 未知
- 状态
- 招募中
- 入组人数
- 80
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Observational
入排标准
- 年龄范围
- 20years-old 至 ot applicable（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •1. severe liver dysfunction (C-P B or C) 2. moderate or severe renal dysfunction 3. gallstone 4. pregnant women
研究者
相似试验
已完成
4 期
The impact of pemafibrate on dyslipidemia in patients with severe adult growth hormone deficiency: A prospective cohort study.dyslipidemiaJPRN-UMIN000038558TT EAST SAPPORO HOSPITA34
已完成
4 期
The impact of pemafibrate on hypertriglyceridemia in patients with type 2 diabetes: A prospective cohort study.dyslipidemiJPRN-UMIN000037385Hokkaido University Hospital650
已完成
4 期
Effects of Bezafibrate on Lipid and glucose metabolism in dyslipidemic patients with impaired glucose tolerance - Comparative analysis of the characteristics of dyslipidemia improving drugs for postprandial metabolic disorder.Patients with metabolic syndromeJPRN-UMIN000008157Department of Cardiovascular Medicine, Juntendo University School of Medicine40
已完成
不适用
Effects of pemafibrate on metabolic parameters in patients with diabetesType 2 diabetes and hypertriglyceridemiaJPRN-UMIN000038160Akishima Clinic27
已完成
不适用
PARADISE in Kagoshima studyhyperlipidemia, Type 2 Diabetes MellitusJPRN-jRCTs071190049ishio Yoshihiko100